Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Phase 1 Recruiting
18 enrolled
Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)
Phase 2 Recruiting
34 enrolled
Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy
Recruiting
2,550 enrolled
Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer
Recruiting
250 enrolled
Postoperative Hypocalcemia After Thyroidectomy
Recruiting
600 enrolled
EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study
Phase NA Recruiting
25 enrolled
Selective Neck Dissection Versus Modified Neck Dissection in PTC
Phase 3 Recruiting
250 enrolled
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
Phase 3 Recruiting
124 enrolled
NISDETECT
Phase NA Recruiting
50 enrolled
177Lu-CTR-FAPI for the Treatment of Thyroid Cancer
Phase 1 Recruiting
12 enrolled
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Phase 1/2 Recruiting
54 enrolled
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
Phase NA Recruiting
1,450 enrolled
New MRI Biomarkers in Head and Neck Cancers
Recruiting
200 enrolled
A Study of Avutometinib and Defactinib in People With Thyroid Cancer
Phase 2 Recruiting
30 enrolled
NeoLATC
Recruiting
120 enrolled
BCB RIV
Phase NA Recruiting
350 enrolled
Improving Care for Rural Patients With Solid Tumors
Phase NA Recruiting
320 enrolled
PharmTRT
Recruiting
600 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
FNA inadequacy
Phase NA Recruiting
160 enrolled
Active Surveillance for Bethesda IV Thyroid Nodules
Phase NA Recruiting
165 enrolled
iCaRe2
Recruiting
999,999 enrolled
Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
Recruiting
1,200 enrolled
Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients
Phase NA Recruiting
88 enrolled
Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer
Phase NA Recruiting
408 enrolled
Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
Phase 2 Recruiting
62 enrolled
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
Phase 1 Recruiting
60 enrolled
RAISE
Phase 2 Recruiting
13 enrolled
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
Phase 1 Recruiting
42 enrolled
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
Phase 2 Recruiting
45 enrolled
MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC
Phase 2 Recruiting
60 enrolled
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Phase 2 Recruiting
13 enrolled
NEO-COMBATXL
Phase 1 Recruiting
12 enrolled
Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer
Phase 3 Recruiting
100 enrolled
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Phase NA Recruiting
40 enrolled
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Recruiting
2,000 enrolled
Personalized Treatment in Thyroid Disorders
Phase NA Recruiting
10 enrolled
INTERMEDIATE
Phase 3 Recruiting
476 enrolled
Identification and Differentiation of Thyroid Nodules by Acoustic Imaging and Viscoelastic Parameters
Recruiting
650 enrolled
Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism
Phase NA Recruiting
160 enrolled
Environmental Factors and Thyroid Cancer
Recruiting
500 enrolled
Patient-centered Dosage of Levothyroxine
Phase NA Recruiting
240 enrolled
PMCAS
Phase NA Recruiting
216 enrolled
TRAIL Study: Feasibility and Pilot
Phase NA Recruiting
20 enrolled
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Phase 1 Recruiting
30 enrolled
THY-CANC
Recruiting
3,000 enrolled
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
Phase 2 Recruiting
22 enrolled
TROP2
Phase 2 Recruiting
32 enrolled
PARTNER
Recruiting
6,250 enrolled
GD
Recruiting
280 enrolled